HbA1c testing in the community pharmacy: A new strategy to improve care for patients with diabetes

Abstract

Get full access to this article

View all access options for this article.

References

It's your health — type 2 diabetes (Health Canada, 2005). Available: www.hc-sc.gc.ca/hl-vs/iyh-vsv/diseases-maladies/diabete-eng.php (accessed August 10, 2011).

Harris

Ékoé

Zdanowicz

Webster-Bogaert

. Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diabetes Res Clin Pract 2005;70:90–7.

Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Available: www.diabetes.ca/files/cpg2008/cpg-2008.pdf (accessed August 10, 2011).

Saaddine

Engelgau

Beckles

. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002;136:565–74.

American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005;28(suppl 1):S4–36.

UK Prospective Diabetes Study Group: intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53.

Holmes

Erşahin

Augustine

. Analytic bias among certified methods for the measurement of hemoglobin A1C: a cause for concern? Am J Clin Pathol 2008;129:540–7.

Al Hamarneh

Rosenthal

Tsuyuki

. Glycemic control in community-dwelling patients with type 2 diabetes. Can Pharm J 2012;145:68–9.